Geron

$1.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-1.64%) As of 3:16 PM UTC today

Why Robinhood?

You can buy or sell Geron and other stocks, options, and ETFs commission-free!

About GERN

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA. The listed name for GERN is Geron Corporation Common Stock.

CEO

John A. Scarlett

Employees

Headquarters

Foster City, California

Founded

1990

Market Cap

549.93M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

2.83M

High Today

$1.73

Low Today

$1.69

Open Price

$1.72

Volume

415.73K

52 Week High

$2.40

52 Week Low

$0.75

Collections

Analyst Ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

GERN Earnings

-$0.20

-$0.13

-$0.07

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 11, After Hours